期刊文献+

铼羰基化合物标记含RGD的多肽 被引量:3

Radiolabeling RGD-Peptide Using fac-[^(188)Re(CO)_3(H_2O)_3]^+
暂未订购
导出
摘要 αvβ3是一种在包括肿瘤引起的血管增生及肿瘤转移中起重要作用的细胞黏附受体,含RGD序列的肽及其类似物可以作为拮抗剂与αvβ3正常配体进行竞争结合。本工作以三羰基铼为前体标记了2个含有RGD序列的多肽,实验结果表明,2个多肽的标记率和放化纯度均大于90%,体外稳定性良好。将进一步对其进行生物评价,以判别其是否有潜力发展成为肿瘤治疗剂。 Integrin αvβ2 is a member of the integrin family, which plays an important role in angiogenesis and tumour metastasis. The peptides containing arginine-glycine-aspartic acid(RGD) sequence can bind to integrin αvβ3 selectively. In the present study, we labeled two RGD-peptides via fac-[^188Re(CO)3 (H2O)3]+. The results show that the labeling yields are more than 90% for both of radiolabeled compounds, and they are all stable in phosphate buffered saline and new-born calf serum, even challenged in histidine or cysteine solution. We will evaluate their biological properties to develop radiolabeled agents for tumor therapy.
出处 《核化学与放射化学》 CAS CSCD 北大核心 2009年第1期23-27,共5页 Journal of Nuclear and Radiochemistry
基金 国家自然科学基金资助项目(20501022 32100601) 中国科学院知识创新工程重大项目(KJCXI-SW-08)
关键词 188Re ΑVΒ3 RGD 188Re,αvβ3 RGD
  • 相关文献

参考文献20

  • 1Zhang Xianzhong, Chen Xiaoyuan. Preparation and Characterization of ^99Tc^m (CO)3 BPy - RGD Complex as αvβ3 Integrin Receptor-Targeted Imaging Agent[J]. Appl Radiat Isot, 2007, 65: 70-78.
  • 2李前伟.肿瘤整合素α_vβ_3受体显像的研究现状[J].国外医学(放射医学核医学分册),2003,27(5):198-200. 被引量:7
  • 3Merdith J E, Fazeli B, Schwartz M A. The Extracellular Matrix as a Cell Survival Factor[J]. Mol Biol Cell, 1993, 4(9): 953-961.
  • 4Brakebusch C, Bouvard D, Stanchi F, et al. Integrins in Invasive Growth[J]. J Clin Invest, 2002, 109: 999-1 006.
  • 5Nicosia R F, Bonanno E. Inhibition of Angiogenesis in Witro by RGD-Containing Synthetic Peptide [J]. Am J Pathol, 1991, 138: 829-833.
  • 6De S, Razorenova O, MeCabe N P, et al. VEGF- Integrin Interplay Controls Tumor Growth and Vascularization[J]. Proc Natl Acad Sci U S A, 2005, 102: 7 589-7 594.
  • 7Robinson S D, Reynolds L E, Wyder L, et al. β3- Integrin Regulates Vascular Endothelial Growth Factor-A-Dependent Permeability [J]. Arterioscler Thromb Vasc Biol, 2004, 24:2 108-2 114.
  • 8Friedlander M, Brooks P C, Shaffer R W, et al. Definition of Two Angiogenic Pathways by Distinct αv Integrins[J]. Science, 1995, 270:1 500-1 502.
  • 9张雷,张才全.整合素与肿瘤[J].重庆医学,2003,32(9):1261-1263. 被引量:6
  • 10Kim J W, Lee H S. Tumor Targeting by Doxorubicin-RGD-4C Peptide Conjugate in an Orthotopic Mouse Hepatoma Model [J]. Int J Mol Med, 2004, 14: 529-535.

二级参考文献33

  • 1Danen EH, Yamada KM. Fibronectin, integrins,and growth control[J]. J Cell Physiol, 2001,189(1):1.
  • 2Takahashi H, Isobe T. Tissue transglutaminase, coagula-tion factor Ⅻ,and the propolypeptide of yon Willebrand factor are all ligands for the integrins alpha 9 beta 1 and alpha 4 betal[J]. J Biol Chem,2000,275(31) :23589.
  • 3Bello DD,Kleinman HK,Webber MM, et al. The role of alpha 6 beta 1 integrin and EGF in normal and malignant acinar morphogenesis of human prostatic epithelial cells [J]. Mutat Res,2001.480:209.
  • 4Owens DM,Watt FM. Influence of beta 1 integrins on epidermal squamous cell carcinoma formation in a transgenic mouse model: alpha 3 betal, but not alpha 2 betal, suppresses malignant conversion [J], Cancer Res, 2001,61(13):5248.
  • 5Witkowski CM, Bowden GT, Nagle RB, et al. Altered surface expression and increased turnover of the alpha 6 beta 4 integrin in an undifferentiated carcinoma[J]. Carcinogenesis, 2000,21(2):325.
  • 6Hamidi S,Salo T,Kainulainen T, er al. Expression of alpha(v) beta 6 integrin in oral leukoplakia[J]. Br J Cancer,2000,82(8):1433.
  • 7Kim S, Bell K, Mousa SA, et al. Regulation of angiogenesis in vivo by ligation of integrin alpha 5 betal with the central cell-binding domain of fibronectin [J]. Am J Pathol, 2000,156(4):1345.
  • 8Carloni V, Mazzocca A, Pantaleo P, et al. The integrin,alpha 6 baeta 1 ,is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocrcinoma cells[J].Hepatology, 2001,34(1):42.
  • 9Thomas GJ,Lewis MP,Whawell SA, et al. Expression of the alpha v beta 6 integrin promotes migration and invasion in squamous carcinoma cells[J]. J Invest Dermatol,2001,117(1):67.
  • 10Genda T, Sakamoto M, Ichida T, et al. Loss of cell-cell contact is induced by integrin-mediated cell-substratum adhesion in highly-motile and highly-metastatic hepatocellular carcinoma cells[J]. Lab Invest,2000,80(3):387.

共引文献13

同被引文献65

  • 1方光光,王迪,唐良振,石文芳.RGD-rAAV2提高卵巢癌细胞体外基因转导效率的研究[J].华中科技大学学报(医学版),2006,35(2):209-212. 被引量:1
  • 2唐林,于俊峰,郑明强,夏姣云,尹端沚.铼[^(188)Re]羰基化合物标记含RGD的环肽及其生物分布[J].核技术,2006,29(6):448-452. 被引量:3
  • 3Janssen ML,Oyen WJ,Dijkgraaf I,et al.Tumor targeting with radiolabeled αvβ3 integrin binding peptides in a nude mouse model[J].Cancer Res,2002,62:6 146-6 151.
  • 4Su ZF,Liu G,Gupta S,et al.In vitro and in vivo evaluation of a technetium-99m-labeled cyclic RGD peptide as a specific marker of αvβ3 integrin for tumor imaging[J].Bioconjug Chem,2002,13:561-570.
  • 5Chen X,Park R,Tohme M,et al.MicroPET and autoradiographic imaging of breast cancer αv-integrin expression using 18F-and 64Cu-labeled RGD peptide[J].Bioconjug Chem,2004,15:41-49.
  • 6Poethko T,Schottelius M,Thumshirn G,et al.Two-step methodology for high-yield routine radiohalogenation of peptides:18F-labeled RGD and octreotide analogs[J].J Nucl Med,2004,45:892-902.
  • 7Chen X,Park R,Shahinlan AH,et al.18F-labeled RGD peptide:initial evaluation for imaging brain tumor angiogenesis[J].Nucl Med Biol,2004,31:179-189.
  • 8Kim JS,Lee KC,Lee BC,et al.Synthesis of fluorine-18 labeled glucose-Lys-Arg-Gly-Asp-D-Phe as a potential tumor imaging agent[J].J Label Compd Radiopharm,2005,48:S289.
  • 9Haubner R,Wester HJ,Reuning U,et al.Radiolabeled αvβ3 integrin antagonists:a new class of tracers for tumor targeting[J].J Nucl Med,1999,40:1 061-1 071.
  • 10Ma Yufei,Yu Junfeng,Han Yanjiang,et al.Radiolabeling RGD peptide and preliminary biodistribution evaluation in mice bearing S180 tumors[J].Nuclear Medicine Communications,2010,31:147-151.

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部